Nav: Home

Study finds opportunity to increase opioid dependence treatment in Ontario jails

February 15, 2018

Hamilton, ON (February 15, 2018) - A study from McMaster University suggests more can be done to improve access to and delivery of opioid dependence treatment in adult correctional facilities in Ontario.

Researchers say collaboration between the health-care and correctional systems is needed to close the gaps, and to benefit and improve the health of those in custody.

The recommendation is based on surveys completed by physicians working in more than half of Ontario's provincial correctional facilities. The study results were published today in PLOS ONE.

"In Canada, research has consistently identified high rates of substance use disorders among people in prison," said Lori Regenstreif, study co-author and assistant clinical professor of family medicine at McMaster.

"Evidence from Ontario, in particular, reveals that the death rate due to overdose is high in this population compared to the general public, especially at the time of release from jail."

The study included completion of an online survey by 27 physicians, who reported working in 15 of 26 provincial correctional facilities for adults in Ontario. This included 10 of the 13 facilities with a population of more than 200.

The study identified that about half of the physicians prescribed methadone and half prescribed buprenorphine/naloxone to treat opioid dependence.

Among physicians who reported prescribing methadone in custody, all 14 reported that they continued methadone treatment if it was initiated in the community but only five (36 per cent) reported they also started patients on this treatment in the correctional facility.

Of the 13 physicians who reported that they prescribed buprenorphine/naloxone, 10 (77 per cent) reported they continued patients on this treatment if they started in the community and only three (23 per cent) started patients on this treatment in the correctional facility.

The most common reasons physicians provided for not prescribing these treatments were not having an exemption to prescribe methadone, other physicians being responsible for the service in the institution, not being interested in adding this treatment to clinical work and not having adequate knowledge about these treatments.

Among the identified barriers to starting patients on these treatments while in prison were concerns about medication diversion and safety, and challenges to care continuity with community-based providers.

"While no published research in Canada has explored these issues, our findings are consistent with the limited research from the United States regarding access to treatment for opioid addiction in prisons," said Regenstreif.

Among the suggestions from the physicians to overcome the barriers for treatment were support from institutional health care and administrative staff, adequate resources for program delivery, and access to linkage with community-based opioid treatment providers.

"Incarceration presents a unique opportunity to offer prevention and treatment to people who use substances and who may otherwise be hard to reach," said Regenstreif.

"The World Health Organization has recommended that all prisoners with opioid use disorders have access to methadone or another related treatment."

The researchers note opioid dependence treatment is a way to reduce harms associated with opioid use, and has been shown to positively impact treatment retention, illicit drug use, drug-related HIV risk behaviours, criminal activity and death in those with an opioid dependence.
-end-
Additional authors for this study were from St. Michael's Hospital, the University of Toronto, Dalhousie University and the Ontario Ministry of Community Safety and Correctional Services.

There was no external funding for this study.

Note to Editors: A photo of Lori Regenstreif, study co-author and assistant clinical professor of family medicine at McMaster, is available.

For more information:

Veronica McGuire
Media Relations
Faculty of Health Sciences
McMaster University
905-525-9140, ext. 22169
vmcguir@mcmaster.ca

McMaster University

Related Health Articles:

Health records pin broad set of health risks on genetic premutation
Researchers from the University of Wisconsin-Madison and Marshfield Clinic have found that there may be a much broader health risk to carriers of the FMR1 premutation, with potentially dozens of clinical conditions that can be ascribed directly to carrying it.
Attitudes about health affect how older adults engage with negative health news
To get older adults to pay attention to important health information, preface it with the good news about their health.
Geographic and health system correlates of interprofessional oral health practice
In the current issue of Family Medicine and Community Health (Volume 6, Number 2, 2018, pp.
Bloomberg era's emphasis on 'health in all policies' improved New Yorkers' heart health
From 2002 to 2013, New York City implemented a series of policies prioritizing the public's health in areas beyond traditional healthcare policies and illustrated the potential to reduce cardiovascular disease risk.
Youth consider mobile health units a safe place for sexual health services
Mobile health units bring important medical services to communities across the country.
More Health News and Health Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...